Загрузка...
Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
Tigilanol tiglate is a novel small molecule approved as a veterinary pharmaceutical in Europe for intratumoural treatment of non-metastatic, non-resectable canine mast cell tumors. The drug has a “tumor agnostic” mode of action associated with induction of an acute inflammatory response at the treat...
Сохранить в:
| Опубликовано в: : | Front Vet Sci |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7509040/ https://ncbi.nlm.nih.gov/pubmed/33033726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2020.00639 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|